CMS adds laboratory drug testing codes, revises IMRT and SRS guidance

Why This Topic Matters

These changes can affect whether claims process correctly, how services are packaged or separately paid, and how providers report related outpatient services under CMS guidance.

Article Sections

1. Laboratory testing codes added

   Discusses the addition of new laboratory drug testing HCPCS codes in the April I/OCE update and the related claim-processing context for outpatient billing.

2. Status indicator and pass-through updates

   Summarizes CMS status indicator changes for selected drug products and notes the addition of new pass-through drugs in the update.

3. Updated guidance

   Covers CMS’s revised billing guidance for IMRT planning and updated clarification for modifier use with stereotactic radiosurgery-related services.